Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1998 | 1 |
2002 | 1 |
2003 | 1 |
2006 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.
J Am Heart Assoc. 2022 Mar;11(5):e020745. doi: 10.1161/JAHA.121.020745. Epub 2022 Feb 18.
J Am Heart Assoc. 2022.
PMID: 35179040
Free PMC article.
Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients.
Serrano-Castro PJ, Fernández-Pérez J, López-González FJ, Toledo-Argany M, Estévez-María JC, Arjona-Padillo A, Bertol-Alegre V, Mauri-Llerda JA, Tortosa-Conesa D, Ruiz-Giménez J, Querol-Pascual R, García-Martínez A, Molto-Jorda JM, Payán-Ortiz M, Maestre-Moreno JF, Galván-Espinosa J; ESL-LIPID Study Group.
Serrano-Castro PJ, et al.
Epilepsy Res. 2017 Dec;138:81-87. doi: 10.1016/j.eplepsyres.2017.10.018. Epub 2017 Oct 29.
Epilepsy Res. 2017.
PMID: 29096133
Item in Clipboard
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group.
Keech A, et al.
Diabetes Care. 2003 Oct;26(10):2713-21. doi: 10.2337/diacare.26.10.2713.
Diabetes Care. 2003.
PMID: 14514569
Clinical Trial.
Item in Clipboard
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study.
Tonkin AM, Eckermann S, White H, Friedlander D, Glasziou P, Magnus P, Kirby A, Mulray S, Denton M, Sallaberger M, Hunt D, Simes J; LIPID Study Group.
Tonkin AM, et al.
Am Heart J. 2006 Jun;151(6):1305-12. doi: 10.1016/j.ahj.2005.07.014.
Am Heart J. 2006.
PMID: 16781242
Clinical Trial.
Item in Clipboard
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease).
LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease).
Lancet. 2002 Apr 20;359(9315):1379-87. doi: 10.1016/S0140-6736(02)08351-4.
Lancet. 2002.
PMID: 11978335
Clinical Trial.
Item in Clipboard
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
N Engl J Med. 1998 Nov 5;339(19):1349-57. doi: 10.1056/NEJM199811053391902.
N Engl J Med. 1998.
PMID: 9841303
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite